Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
By S. Grundy, J. Cleeman, Noel, B. Merz, H Bryan Brewer, L. Clark, D. Hunninghake, R. Pasternak, Sidney C. Smith, N. Stone. Journal of the American College of Cardiology, 2004
6,622 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/0b619d2e62639a0fabe419d6a52cb5e9945318bd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- I. Graham
- Yun Li
- D. Mozaffarian
- Børge G. Nordestgaard
- Cristen J. Willer
- Gonçalo R. Abecasis
- Massimo F. Piepoli
- Michael J. Pencina
Citations in the corpus
- Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. (2011, background): “International guidelines have identified LDL cholesterol and, in some cases, non-HDL cholesterol or Apo B as targets for therapy (Table 4).(1,13,17,20,23,78) The U.”
- Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. (2005, methodology): “chronic disease by national and international medical organizations using the National Guideline Clearinghouse.(14-42)”
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009, background): “Readers are referred to published guidelines for a discussion of the rationale and goals of therapy for the nonglycemic risk factors, as well as recommendations on how to achieve them (1,21,22).”